Przejdź do zawartości
Merck

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Chest (1998-03-14)
P W Wong, N Macris, L DiFabrizio, N S Seriff
ABSTRAKT

A 69-year-old man with advanced prostate cancer was receiving antiandrogen therapy (bicalutamide [Casodex]). He developed dyspnea, peripheral eosinophilia and bilateral pulmonary interstitial infiltrates. Transbronchial biopsy confirmed pulmonary eosinophilia. Withdrawal of bicalutamide and initiation of steroid therapy resulted in clinical improvement.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Bicalutamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Bicalutamide (CDX), ≥98% (HPLC), powder
Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard